期刊文献+

新型吡啶氮唑氮芥化合物与线粒体的作用及其抗肿瘤活性

Effect of Novel Pyridine Nitrogen Mustard Compound onMitochondria and Its Anti-tumor Activity
下载PDF
导出
摘要 线粒体是抗肿瘤药物的重要靶点,研究药物分子与线粒体之间的作用有助于明确药物作用机制。设计并合成了靶向线粒体类抗肿瘤药物新型吡啶氮唑氮芥化合物N,N'-(1,1'-(吡啶-2,6-二取代双(亚甲基))双(1H-1,2,3-三唑-4,1-二基))双(亚甲基)双(2-氯-N-(2-氯乙基)乙胺),探究了其抗肿瘤作用机制,用MTT法检测了该化合物的细胞毒性作用,发现其对A549细胞表现出良好的抑制作用。该化合物作用于A549细胞引起细胞凋亡,DCFH-DA及JC-1染色表明该化合物通过引发细胞内ROS水平升高,继而引发线粒体功能障碍,途径诱导A549细胞凋亡。WB结果表明细胞凋亡的线粒体途径中凋亡促进蛋白Bax表达水平升高,凋亡抑制蛋白Bcl-2表达水平降低,进一步证实了该化合物通过线粒体途径引发A549细胞凋亡。 Mitochondria are important targets of anti-tumor drugs.Studying the interaction between drug molecules and mitochondria will help clarify the mechanism of drug action.A novel pyridine nitrogen mustard compound N,N'-(1,1'-(pyridine-2,6-disubstituted bis(methylene))bis(1H-1,2,3-triazole-4,1-diyl))bis(Methylene)bis(2-chloro-N-(2-chloroethyl)ethylamine)was designed and synthesized and its antitumor mechanism was explored.The MTT kit was used to detect the cytotoxicity of this compound,and it was found that the compound showed a good inhibitory effect on A549 cell.The compound acted on A549 cell leading to cell apoptosis.DCFH-DA and JC-1 staining indicated that the compound induced A549 cell apoptosis by triggering the increase of intracellular ROS levels,which in turn triggered mitochondrial dysfunction pathway.WB results showed that the pro-apoptotic gene Bax protein expression increased in the mitochondrial pathway of apoptosis,and the apoptosis inhibitor gene Bcl-2 expression decreased at the protein level,further confirming that the compound triggered A549 cell apoptosis through the mitochondrial pathway.
作者 曹守莹 CAO Shouying(School of Public Foundation,Bengbu Medical College,Bengbu Anhui 233030)
出处 《湖北理工学院学报》 2021年第1期56-61,共6页 Journal of Hubei Polytechnic University
基金 蚌埠医学院自然科学基金项目(项目编号:BYKY1753)。
关键词 新型吡啶氮唑氮芥化合物 抗肿瘤活性 A549细胞 凋亡 novel pyridine nitrogen mustard compound anti-tumor activity A549 cells apoptosis
  • 相关文献

参考文献8

二级参考文献65

  • 1关丽英,许彩民,潘华珍.内质网应激介导的细胞凋亡[J].生物化学与生物物理进展,2007,34(11):1136-1141. 被引量:76
  • 2HENGARTNER M O. The biochemistry of apoptosis[J]. Nature, 2000,407(6805) :770-776.
  • 3MARTINOU J C, DESAGHER S, ANTONSSON B. Cytochrome c release from mitoehondria: all or nothing[J]. Nat Cell Biol, 2000,2(3) :E41- E43.
  • 4HANAHAN D,WEINBERG R A. The hallmarks of cancer[J]. Cell,2000,100(1) :57-70.
  • 5HAYDEN E C. Cancer complexity slows quest for cure[J]. Na ture,2008,455(7210) :148.
  • 6CAIMS R A,HARRIS I S,MAK T W. Regulation of cancer cell metabolism[J]. Nat Rev Cancer, 2011,11 (2) : 85-95.
  • 7GOGVADZE V, ORRERENIUS S, ZHIVOTOSKY g. Mitochon dria in cancer cells:what is so special about them? [J]. Trends C- eil Biol, 2008,18(4) : 165-173.
  • 8GOGVADZE V, ORRERENIUS S, ZHIVOTOSKY B. Mitochon- dria as targets for cancer chemotherapy[J]. Semin Cancer Biol, 2009,19(1) :57-66.
  • 9PEDERSEN P L. Voltage dependent anion channels (VDACs) :a brief introduction with a focus on the outer mitoehondrial com- partments roles together with hexokinase-2 in the "Warburg effect" in cancer[J]. J Bioenerg Biomembr,2008,40(3):123 -126.
  • 10MATHUPALA S P,KO Y H,PEDERSEN P L. Hexokinase ]I : cancer's double-edged sword acting as both facilitator and gate- keeper of malignancy when bound to mitochondria[J]. Oncogene, 2006,25(34) :4777-4786.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部